dosage regimen

dosage regimen

The schedule of doses of a therapeutic agent per unit of time, including: the time between doses (e.g., every 6 hours) or the time when the dose(s) are to be given (e.g., at 8 a.m. and 4 p.m. daily), and the amount of a medicine (e.g., number of capsules) to be given at each specific time.
References in periodicals archive ?
With the exception of the number of prior lines of treatment, the eligibility criteria were similar to and the dosage regimen identical to KEYNOTE-181.
The present study aimed to investigate the interspecies variations in relation to pharmacokinetic profile and optimal dosage regimen of amoxicillin in Lohi sheep and Beetal goats.
The model might be used in initiating a vancomycin dosage regimen in the type of patient similar to the present study.
In comparison with FIGO 2017 misoprostol recommendations, we found that a lower and less vigorous dosage regimen of mifepristone and misoprostol is efficacious in achieving second trimester MTP.
The optimized dosage regimen for the reference drug (informed in package inserts to guide prescribers and patients) relies on the empiric evidence arising from clinical trials conducted by the pharmaceutical company.
Sponsored by specialist Spanish biotech company Araclon Biotech, a Grifols company, this phase II of the study is designed to establish the dosage regimen for the therapy, as well as confirm the treatment safety and tolerability data obtained in phase I.
A once-daily PER dosage regimen permits smaller plasma concentration fluctuation and better convenience of use compared to those from a thrice-daily pramipexole IR (PIR) regimen [10].
Traditionally, medications are measured in the appropriate matrix (serum, plasma, or whole blood) and are used to individualize the dosage regimen with the intent to maximize efficacy and minimize toxicity.
This study showed that changing the dosage regimen of morphine administration could be useful for the management of withdrawal syndrome and cortisol (as the main marker of anxiety) of the cessation period.
Of the 1092 consecutively admitted cirrhotics, 198 were excluded for hepatocellular carcinoma, 710 for non-HCV-related disease (586 HBV, 65 alcoholic, 58 biliary cirrhosis and one patients with haemochromatosis), 37 for inadequate liver function (Child-Pugh class C), 28 for chronic invalidating disease (such as unstable cardiovascular disease, chronic renal failure, or severe chronic obstructive lung disease), 23 for being older than 65 years, 5 for previous combination antiviral therapy, 28 for refusing to be treated, and 50 patients with moderate hypersplenism and portal hypertension received pegylated/standard IFN-[alpha] plus ribavirin combination therapy with a low accelerating dosage regimen for 48 weeks (partial results has been described in previous study (5)).
For patients on twice a day dosage regimen, reduce the morning dose to 75% and should be given at Iftar, reduce the night dose to 50% and should be taken at Sehar.
This includes the patient INR [blood clotting measurement] and dosage regimen being sent to the GP to ensure no breaks in the communication loop.